# Opus Genetics, Inc.: Form 10-K for the period ended Dec 31, 2017

- Company: [Opus Genetics, Inc.](/companies/ird.md) (CIK 1228627)
- Form: 10-K
- Filed: 2018-03-09
- Accepted by EDGAR: Mar 9, 2018, 16:16 ET
- Period: 2017-12-31
- Accession: 0001140361-18-012817
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1228627/000114036118012817/form10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1228627/000114036118012817/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2017-01-01 to 2017-12-31 | $10.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2017-10-01 to 2017-12-31 | −$4.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months, 2017-01-01 to 2017-12-31 | −$17.4m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2017-10-01 to 2017-12-31 | −$3.6m | us-gaap:NetIncomeLoss |
| Net income | 12 months, 2017-01-01 to 2017-12-31 | −$25.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-10-01 to 2017-12-31 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months, 2017-01-01 to 2017-12-31 | −$0.92 | us-gaap:EarningsPerShareBasicAndDiluted |
| Basic EPS | 3 months, 2017-10-01 to 2017-12-31 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Cash and equivalents | at 2017-12-31 | $8.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-12-31 | $28.1m | us-gaap:AssetsCurrent |
| Total assets | at 2017-12-31 | $28.3m | us-gaap:Assets |
| Total liabilities | at 2017-12-31 | $11.5m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-12-31 | $16.8m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1228627/000114036118012817/form10k.htm

Filed Mar 9, 2018.
Source: SEC EDGAR, the filing index for accession 0001140361-18-012817. Last ingested by Listed: Nov 12, 2026, 19:22 ET. No prices; not investment advice.
